---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-000919"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2025-01-29T23:59:59+00:00"
generated_at: "2026-05-27T06:35:24.430392+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv FY2024 rev $9.5M (-$7.5M YoY), net loss $0.8M; declares $0.075 special dividend

## Summary
- Revenue for year ended Oct 31, 2024 approximately $9.5M, a decrease of $7.5M from prior year.
- Net loss of approximately $0.8M compared to net income of $1.3M in the prior year.
- Board approved a Special Dividend of $0.075 per share payable on or about March 20, 2025.
- CEO cited challenging industry conditions in 2024; focused on higher-value services and new technologies.

## SEC filing metadata
- accession: 0001654954-25-000919
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2025-01-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495425000919/0001654954-25-000919-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495425000919/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-000919
- JSON: https://secwatch.observer/filing/0001654954-25-000919.json
- Plain text: https://secwatch.observer/filing/0001654954-25-000919.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.